A model for predicting size distributions delivered from pMDIs with suspended drug

International Journal of Pharmaceutics

Volumn 422, Issue 1-2, 2012, Pages 101-115

  Stein, Stephen W ^a   Sheth, Poonam ^b   Myrdal, Paul B ^b  

^a 3M COMPANY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Aerodynamic particle size; Pressurized metered dose inhaler (pMDI); Simulation model; Suspension formulation

Indexed keywords

EXCIPIENT;

ACCURACY; AEROSOL; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG FORMULATION; METERED DOSE INHALER; PARTICLE SIZE; PRESSURED METERED DOSE INHALER; PRIORITY JOURNAL; SIMULATION; SUSPENSION;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; METERED DOSE INHALERS; MODELS, CHEMICAL; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84655176372     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.10.035     Document Type: Article

References (32)

1. P.J. Atkins Chloroflurocarbon to hydrofluroalkane formulations: an industry perspective J. Allergy Clin. Immunol. 104 1999 S268 S270
2. G. Brambilla, D. Ganderton, R. Garzia, D. Lewis, B. Meakin, and P. Ventura Modulation of aerosol clouds produced by pressurized inhalation aerosols Int. J. Pharm. 186 1999 53 61 (Pubitemid 29397522)
3. H. Chan, and I. Gonda Development of a systematic theory of suspension inhalation aerosols. II. Aggregates of monodisperse particles nebulized into polydisperse droplets Int. J. Pharm. 41 1988 157
4. Y.S. Cheng, B.T. Chen, H.C. Yeh, I.A. Marshall, J.P. Mitchell, and W.D. Griffiths Behavior of compact nonspherical particles in the TSI Aerodynamic Particle Sizer Model APS33B: ultra-Stokesian drag forces Aerosol Sci. Technol. 19 1993 255 267 (Pubitemid 23284684)
5. C.N. Davies Particle-fluid interaction J. Aerosol Sci. 10 1979 477 513
6. C.A. Dunbar Atomization mechanisms of the pressurized metered dose inhaler Part. Sci. Technol. 15 1997 253 271 (Pubitemid 28449122)
7. C.A. Dunbar, A.P. Watkins, and J.F. Miller An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques J. Aerosol Med. 10 1997 351 368 (Pubitemid 28006475)
8. S.V. Fulzele, M.S. Shaik, A. Chatterjee, and M. Singh Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549 J. Pharm. Pharmacol. 58 2006 327 336 (Pubitemid 43344575)
9. I. Gonda Development of a systematic theory of suspension inhalation aerosols. I. A framework to study the effects of aggregation on the aerodynamic behaviour of drug particles Int. J. Pharm. 27 1985 99 116 (Pubitemid 15246926)
10. L. Harrison, C. Leach, J. Machacek, J. Vanden Burgt, and J. Vogel Beneficial effects with reduced particle size and CFC-free extrafine aerosol steroid on lung deposition, absorption, efficacy and safety Am. J. Respir. Crit. Care Med. 155 1997 A666
11. T. Hatch, and S.P. Choate Statistical description of the size properties of non-uniform particulate substances J. Franklin Inst. 207 1929 269 287
12. A.J. Hickey, T.B. Martonen, and Y. Yang Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols Pharm. Acta Helvet. 71 1996 185 190 (Pubitemid 26290616)
13. P.H. Howarth Why particle size should affect clinical response to inhaled therapy J. Aerosol Med. 14 2001 S27 S34
14. J. James, B. Crean, M. Davies, R. Toon, P. Jinks, and C.J. Roberts The surface charaterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers Int. J. Pharm. 361 2008 209 221
15. P.A. Jinks Preparation and utility of sub-micron lactose, a novel excipient for HFA MDI suspension formulations Conference Proceedings of Drug Delivery to the Lungs XIV London 2003 199 202
16. C. Kapitza, T. Heise, M. McGovern, E. Cefali, A. Buchwald, L. Heinemann, and M. Hompesch Time-action profile of a new pulmonary insulin applied with a metered dose inhaler American Diabetes Association, 63rd Scientific Session, June 13-17, 2003 New Orleans, LA 2003
17. N.R. Labiris, and M.B. Dolovich Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications Br. J. Clin. Pharmacol. 56 2003 600 612 (Pubitemid 37491711)
18. C. Leach The CFC to HFA transition and its impact on pulmonary drug development Respir. Care 50 2005 1201 1206 (Pubitemid 46173335)
19. C.L. Leach, W.M. Hameister, M.A. Tomai, D.M. Hammerbeck, and J.S. Stefely Oligolactic acid (OLA) biomatrices for sustained release of asthma therapeutics R.N. Dalby, P.R. Byron, S.J. Farr, J. Peart, Respiratory Drug Delivery VII 2000 Serentec Press Inc Raleigh, NC 75 81
20. M.D. Louey, and L. Garcia-Contreras Controlled release products for respiratory delivery Am. Pharm. Rev. 7 2004 82 87 (Pubitemid 39220411)
21. L. McKenzie, and M.J. Oliver Evaluation of the particle formation process after actuation of solution MDIs J. Aerosol Med. 13 2000 59
22. P.B. Myrdal, K.L. Karlage, S.W. Stein, B.A. Brown, and A. Haynes Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane- based metered dose inhalers J. Pharm. Sci. 93 2004 1054 1061 (Pubitemid 38420415)
23. O.G. Raabe The dilution of monodispersed suspensions for aerosolization Am. Ind. Hyg. Assoc. J. 29 1968 439 443
24. D.L. Ross, and B.J. Gabrio Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system J. Aerosol Med. 12 1999 151 160 (Pubitemid 29441625)
25. H. Shi, and C. Kleinstreuer Simulation and analysis of high-speed droplet spray dynamics J. Fluids Eng. 129 2007 621 633 (Pubitemid 46969944)
26. H.D.C. Smyth, and A.J. Hickey Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers AAPS Pharm. Sci. Technol. 4 2003 (article 38)
27. S.W. Stein The influence of sample size on the accuracy of particle size distribution measurements R.N. Dalby, P.R. Byron, J. Peart, J.D. Suman, S.J. Farr, P.M. Young, Respiratory Drug Delivery 2008 2008 Davis Healthcare International Publishing, LLC River Grove, IL 333 336
28. S.W. Stein Estimating the number of droplets and drug particles emitted from MDIs AAPS Pharm. Sci. Technol. 9 2008 112 115
29. S.W. Stein, and P.B. Myrdal A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions J. Pharm. Sci. 93 2004 2158 2175 (Pubitemid 39045494)
30. S.W. Stein, and P.B. Myrdal The relative influence of atomization and evaporation on metered dose inhaler drug delivery efficiency Aerosol Sci. Technol. 40 2006 335 347
31. S. Stein, P. Sheth, C. Karayiannis, H. Chiou, and P. Myrdal Modeling MDI delivery: a prior predictions, empirical models, and experiments R.N. Dalby, P.R. Byron, J. Peart, J.D. Suman, S.J. Farr, P.M. Young, Respiratory Drug Delivery 2010 2010 Davis Healthcare International Publishing, LLC River Grove, IL 353 364
32. J.Y. Zheng, M. Fulu, D.Y. Lee, T.E. Barber, and A.L. Adjei Pulmonary peptide delivery: effect of taste-masking excipients on leuprolide suspension metered-dose inhalers Pharm. Dev. Technol. 6 2001 521 530 (Pubitemid 34014960)